Skip to main content

Table 4 Microorganisms responsible for infections and MDRO acquired colonization

From: Multiple-site decontamination to prevent acquired infection in patients with veno-venous ECMO support

Variables

SC

MSD

p-value

Ventilator-associated pneumonia

n = 107

n = 16

 

Staphylococcus aureus—no. (%)

3 (2.8)

2 (12.5)

0.126

Streptococcus sp.—no. (%)

2 (1.9)

1 (6.2)

0.344

Enterococcus sp.—no. (%)

13 (12.1)

4 (25.0)

0.235

Enterobacteriaceae– no. (%)

24 (22.4)

4 (25.0)

0.758

Non-fermenting Gram-negative bacilli—no. (%)

48 (44.9)

2 (12.5)

0.015

Others—no. (%)

17 (15.9)

3 (18.8)

0.724

Respiratory sample for first VAP diagnosis

n = 58

n = 12

0.36

Broncho-alveolar lavage

50 (86)

9 (75)

 

Endo-tracheal aspirate

8 (14)

3 (25)

 

Bloodstream infection

n = 40

n = 8

 

Staphylococcus aureus—no. (%)

1 (2.5)

0 (0.0)

1.000

Coagulase negative Staphylococcus—no. (%)

4 (10.0)

0 (0.0)

1.000

Streptococcus sp.—no. (%)

2 (5.0)

0 (0.0)

1.000

Enterococcus sp.—no. (%)

11 (27.5)

5 (62.5)

0.097

Enterobacteriaceae—no. (%)

8 (20.0)

1 (12.5)

1.000

Non-fermenting Gram-negative bacilli—no. (%)

5 (12.5)

0 (0.0)

0.573

Candida sp.—no. (%)

8 (20.0)

0 (0.0)

0.320

Others—no. (%)

1 (2.5)

2 (25.0)

0.068

MDRO acquired colonization

n = 30

n = 2

 

Carbapenem resistant

5 (16.7)

0 (0.0)

1.000

 Acinetobacter baumannii—no. (%)

3 (10.0)

0 (0.0)

1.000

 Klebsiella pneumonia—no. (%)

1 (3.3)

0 (0.0)

1.000

ESBL-PE

25 (83.3)

2 (100.0)

1.000

 Klebsiella pneumonia—no. (%)

7 (23.3)

0 (0.0)

1.000

 Citrobacter freundii—no. (%)

1 (3.3)

0 (0.0)

1.000

 Escherichia coli—no. (%)

5 (16.7)

2 (100.0)

0.042

 Enterobacter cloacae—no. (%)

12 (40.0)

0 (0.0)

0.516

Others

   

MDR- Pseudomonas aeruginosa—no. (%)

1 (3.3)

0 (0.0)

1.000

  1. SC: standard care. MSD: multiple-site decontamination. VAP: ventilator-associated pneumonia. MDRO: multidrug-resistant microorganisms. ESBL-PE: extended spectrum beta lactamase producing Enterobacteriaceae